Clarify the Role of Kynmobi for Parkinson's Disease
February 2021
Kynmobi (apomorphine) sublingual film will be a new option for "off" episodes in Parkinson's disease.
It's a quick-acting dopamine agonist...for symptoms (tremor, etc) that return between carbidopa/levodopa doses, especially in advanced Parkinson's disease.
Kynmobi will be used "on demand"...similar to Movapo (apomorphine) subcutaneous injection.
Upgrade now to access this resource
This content is not available under the subscriptions purchased by your organization, but you can add it on!
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive